1. High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma via the NF-κB Pathway in MG63 Cells
   Yang Lu et al, 2023, Current Cancer Drug Targets CrossRef
2. CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle
   Hao-Yu Zhou et al, 2024, Oncology Letters CrossRef
3. Structural and energetic insights into the selective inhibition of PKMYT1 against WEE1
   Xuesen Qi et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
4. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma
   Junbo Zhang et al, 2024, Medicine CrossRef
5. PKMYT1 induced by YAP/TEAD1 gives rise to the progression and worse prognosis of bladder cancer
   Maoyu Wang et al, 2024, Molecular Carcinogenesis CrossRef